98 related articles for article (PubMed ID: 27355867)
1. Arg188 drives RhoC membrane binding.
Patel A; Williams-Perez S; Peyton N; Reicks A; Buzick J; Farley J; Shirar S; Ellerbroek SM
Small GTPases; 2017 Apr; 8(2):114-121. PubMed ID: 27355867
[TBL] [Abstract][Full Text] [Related]
2. RhoC regulates the actin remodeling required for phagosome formation during FcγR-mediated phagocytosis.
Egami Y; Kawai K; Araki N
J Cell Sci; 2017 Dec; 130(24):4168-4179. PubMed ID: 29113998
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells.
Reinhard NR; van Helden SF; Anthony EC; Yin T; Wu YI; Goedhart J; Gadella TW; Hordijk PL
Sci Rep; 2016 May; 6():25502. PubMed ID: 27147504
[TBL] [Abstract][Full Text] [Related]
4. Activation of RhoC by regulatory ubiquitination is mediated by LNX1 and suppressed by LIS1.
Kholmanskikh S; Singh S; Ross ME
Sci Rep; 2022 Oct; 12(1):16493. PubMed ID: 36192543
[TBL] [Abstract][Full Text] [Related]
5. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells.
Rolli-Derkinderen M; Sauzeau V; Boyer L; Lemichez E; Baron C; Henrion D; Loirand G; Pacaud P
Circ Res; 2005 Jun; 96(11):1152-60. PubMed ID: 15890975
[TBL] [Abstract][Full Text] [Related]
7. RhoA and RhoC are involved in stromal cell-derived factor-1-induced cell migration by regulating F-actin redistribution and assembly.
Luo J; Li D; Wei D; Wang X; Wang L; Zeng X
Mol Cell Biochem; 2017 Dec; 436(1-2):13-21. PubMed ID: 28536953
[TBL] [Abstract][Full Text] [Related]
8. Toward Novel Diagnostics for Primary Open-Angle Glaucoma? An Association Study of Polymorphic Variation in Ras Homolog Family Member (A, B, C, D) Genes RHOA, RHOB, RHOC, and RHOD.
Saracaloglu A; Demiryürek S; Okumus S; Oztuzcu S; Bozgeyik I; Coskun E; Aksoy U; Kaydu E; Erbagci I; Gürler B; Alasehirli B; Demiryürek AT
OMICS; 2016 May; 20(5):290-5. PubMed ID: 27195967
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.
Wu M; Wu ZF; Rosenthal DT; Rhee EM; Merajver SD
Cancer; 2010 Jun; 116(11 Suppl):2768-82. PubMed ID: 20503409
[TBL] [Abstract][Full Text] [Related]
10. Endothelial RhoB and RhoC are dispensable for leukocyte diapedesis and for maintaining vascular integrity during diapedesis.
Schimmel L; de Ligt A; Tol S; de Waard V; van Buul JD
Small GTPases; 2020 May; 11(3):225-232. PubMed ID: 28960175
[TBL] [Abstract][Full Text] [Related]
11. X-ray crystal structures reveal two activated states for RhoC.
Dias SM; Cerione RA
Biochemistry; 2007 Jun; 46(22):6547-58. PubMed ID: 17497936
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
13. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
[TBL] [Abstract][Full Text] [Related]
14. A RhoC biosensor reveals differences in the activation kinetics of RhoA and RhoC in migrating cells.
Zawistowski JS; Sabouri-Ghomi M; Danuser G; Hahn KM; Hodgson L
PLoS One; 2013; 8(11):e79877. PubMed ID: 24224016
[TBL] [Abstract][Full Text] [Related]
15. Nanobody-Based Quantification of GTP-Bound RHO Conformation Reveals RHOA and RHOC Activation Independent from Their Total Expression in Breast Cancer.
Keller L; Tardy C; Ligat L; Gilhodes J; Filleron T; Bery N; Rochaix P; Aquilina A; Bdioui S; Roux T; Trinquet E; Favre G; Olichon A
Anal Chem; 2021 Apr; 93(15):6104-6111. PubMed ID: 33825439
[TBL] [Abstract][Full Text] [Related]
16. cGMP-dependent protein kinase phosphorylates and inactivates RhoA.
Sawada N; Itoh H; Yamashita J; Doi K; Inoue M; Masatsugu K; Fukunaga Y; Sakaguchi S; Sone M; Yamahara K; Yurugi T; Nakao K
Biochem Biophys Res Commun; 2001 Jan; 280(3):798-805. PubMed ID: 11162591
[TBL] [Abstract][Full Text] [Related]
17. Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation.
Bueno De Paiva L; Aline Bernusso V; Machado-Neto JA; Traina F; Ridley AJ; Olalla-Saad ST; Lazarini M
Small GTPases; 2021 Jan; 12(1):20-26. PubMed ID: 30449238
[TBL] [Abstract][Full Text] [Related]
18. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.
Simpson KJ; Dugan AS; Mercurio AM
Cancer Res; 2004 Dec; 64(23):8694-701. PubMed ID: 15574779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
